A 3 year experience of national haemovigilance: Practical consequences for viral contamination;Les retombees pratiques des 3 ans d'experience de l'hemovigilance nationale en matiere de complications virales

Transfusion Clinique et Biologique

Volumn 5, Issue 3, 1998, Pages 211-218

  Laperche, S ^a  

^a Inst Natl de la T   (France)

Author keywords

Haemovigilance; HBV; HCV; HIV; Residual risk; Transfusion

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; CONTAMINATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; QUALITY CONTROL; RISK ASSESSMENT; VIRUS TRANSMISSION; BLOOD BANK; DISEASE TRANSMISSION; FRANCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; RISK FACTOR; STANDARD; VIRUS INFECTION;

BLOOD BANKS; BLOOD TRANSFUSION; FRANCE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK FACTORS; VIRUS DISEASES;

EID: 0032105438     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(98)80413-8     Document Type: Conference Paper

References (13)

1. 1 Schreiber GB, Busch MP, Kleiman SH, Korelitz JJ for the NHLBI Retrovirus Epidemiology Blood Donor Study. Current risk of transfusion-transmitted viral infections and impact of new donor screening tests. N Engl J Med 1996 ; 334 : 1685-90
2. 2 Couroucé AM, Pillonel J et les groupes de travail de la SFTS. Risque de transmission d'infection virale par transfusion de dérivés sanguins labiles. Méd Thér 1997 ; 3 : 858-62
3. 3 Couroucé AM, Pillonel J et les responsables d'ETS appartenant aux groupes de travail Rétrovirus et Hépatites virales de la SFTS. Estimation du risque de transmission des virus des hépatites B et C et des rétrovirus humains par transfusion de dérivés sanguins labiles. Transfus Clin Biol 1996 ; 1 : 13-8
4. 4 Couroucé AM, Pillonel J for the Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. Transfusion-transmitted viral infections. N Engl J Med 1996 ; 335 : 1609-10
5. 5 Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL et al, and the Transfusion Safety Group. Infection with Human Immunodeficiency Virus Type 1 (VIH-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990 ; 113 : 733-9
6. 6 Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992 ; 51 : 886-91
7. 7 Herr V, Ambruso D, Fairfax M, Neumann A, Swanson P, Lee H. Transfusion-associated transmission of human T-lymphotropic virus types I and II : experience of a regional blood center. Transfusion 1993 ; 33 : 208-201
8. 8 Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE et al. Time course of detection of viral and serologie markers preceeding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995 ; 35 : 91-7
9. 9 Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993 ; 307 : 1095-7
10. 10 Fong TL, Di Bisceglie AM, Biswas R, Waggoner JG, Wilson L, Claggett J et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 1994 ; 43 : 155-8
11. 11 Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J et al. Improved detection of anti-VHC in post-transfusion hepatitis by a third-generation Elisa. Vox Sang 1995 ; 68 : 15-8
12. 12 Elghouzzi MH, Couroucé AM, Magnius LO, Lunel F, Lapierre V. Transmission of hepatitis B virus by VHB-negative blood transfusion. Lancet 1995 ; 346 : 964
13. 13 Laperche S, Moreau P, Lair J, Couroucé AM. Two successive HIV contaminations from subjects in window period. AIDS (accepté pour publication)